These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 36421302)
21. Next-Generation Technologies and Systems Biology for the Design of Novel Vaccines Against Apicomplexan Parasites. Tomazic ML; Marugan-Hernandez V; Rodriguez AE Front Vet Sci; 2021; 8():800361. PubMed ID: 35071390 [TBL] [Abstract][Full Text] [Related]
22. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening. Deng Y; Wu T; Zhai SQ; Li CH Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276 [TBL] [Abstract][Full Text] [Related]
23. Guanabenz repurposed as an antiparasitic with activity against acute and latent toxoplasmosis. Benmerzouga I; Checkley LA; Ferdig MT; Arrizabalaga G; Wek RC; Sullivan WJ Antimicrob Agents Chemother; 2015 Nov; 59(11):6939-45. PubMed ID: 26303803 [TBL] [Abstract][Full Text] [Related]
24. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria. Stanisic DI; Ho MF; Nevagi R; Cooper E; Walton M; Islam MT; Hussein WM; Skwarczynski M; Toth I; Good MF mBio; 2021 Oct; 12(5):e0265721. PubMed ID: 34663097 [TBL] [Abstract][Full Text] [Related]
25. The Naumov A; Kratzer S; Ting LM; Kim K; Suvorova ES; White MW mBio; 2017 Aug; 8(4):. PubMed ID: 28830940 [TBL] [Abstract][Full Text] [Related]
26. Stem cell-derived enteroid cultures as a tool for dissecting host-parasite interactions in the small intestinal epithelium. Hares MF; Tiffney EA; Johnston LJ; Luu L; Stewart CJ; Flynn RJ; Coombes JL Parasite Immunol; 2021 Feb; 43(2):e12765. PubMed ID: 32564379 [TBL] [Abstract][Full Text] [Related]
27. MicroRNAs in the Host-Apicomplexan Parasites Interactions: A Review of Immunopathological Aspects. Judice CC; Bourgard C; Kayano AC; Albrecht L; Costa FT Front Cell Infect Microbiol; 2016; 6():5. PubMed ID: 26870701 [TBL] [Abstract][Full Text] [Related]
28. Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites. Bellini V; Swale C; Brenier-Pinchart MP; Pezier T; Georgeault S; Laurent F; Hakimi MA; Bougdour A iScience; 2020 Dec; 23(12):101871. PubMed ID: 33336164 [TBL] [Abstract][Full Text] [Related]
29. The plant-type ferredoxin-NADP+ reductase/ferredoxin redox system as a possible drug target against apicomplexan human parasites. Seeber F; Aliverti A; Zanetti G Curr Pharm Des; 2005; 11(24):3159-72. PubMed ID: 16178751 [TBL] [Abstract][Full Text] [Related]
30. Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum. Khan SM; Garcia Hernandez A; Allaie IM; Grooms GM; Li K; Witola WH; Stec J Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():6-20. PubMed ID: 35462232 [TBL] [Abstract][Full Text] [Related]
31. In situ ultrastructures of two evolutionarily distant apicomplexan rhoptry secretion systems. Mageswaran SK; Guérin A; Theveny LM; Chen WD; Martinez M; Lebrun M; Striepen B; Chang YW Nat Commun; 2021 Aug; 12(1):4983. PubMed ID: 34404783 [TBL] [Abstract][Full Text] [Related]
33. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728 [TBL] [Abstract][Full Text] [Related]
34. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis. Baragaña B; Forte B; Choi R; Nakazawa Hewitt S; Bueren-Calabuig JA; Pisco JP; Peet C; Dranow DM; Robinson DA; Jansen C; Norcross NR; Vinayak S; Anderson M; Brooks CF; Cooper CA; Damerow S; Delves M; Dowers K; Duffy J; Edwards TE; Hallyburton I; Horst BG; Hulverson MA; Ferguson L; Jiménez-Díaz MB; Jumani RS; Lorimer DD; Love MS; Maher S; Matthews H; McNamara CW; Miller P; O'Neill S; Ojo KK; Osuna-Cabello M; Pinto E; Post J; Riley J; Rottmann M; Sanz LM; Scullion P; Sharma A; Shepherd SM; Shishikura Y; Simeons FRC; Stebbins EE; Stojanovski L; Straschil U; Tamaki FK; Tamjar J; Torrie LS; Vantaux A; Witkowski B; Wittlin S; Yogavel M; Zuccotto F; Angulo-Barturen I; Sinden R; Baum J; Gamo FJ; Mäser P; Kyle DE; Winzeler EA; Myler PJ; Wyatt PG; Floyd D; Matthews D; Sharma A; Striepen B; Huston CD; Gray DW; Fairlamb AH; Pisliakov AV; Walpole C; Read KD; Van Voorhis WC; Gilbert IH Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7015-7020. PubMed ID: 30894487 [TBL] [Abstract][Full Text] [Related]
35. Targeting Channels and Transporters in Protozoan Parasite Infections. Meier A; Erler H; Beitz E Front Chem; 2018; 6():88. PubMed ID: 29637069 [TBL] [Abstract][Full Text] [Related]
36. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614 [TBL] [Abstract][Full Text] [Related]
37. Assessing viability and infectivity of foodborne and waterborne stages (cysts/oocysts) of Giardia duodenalis, Cryptosporidium spp., and Toxoplasma gondii: a review of methods. Rousseau A; La Carbona S; Dumètre A; Robertson LJ; Gargala G; Escotte-Binet S; Favennec L; Villena I; Gérard C; Aubert D Parasite; 2018; 25():14. PubMed ID: 29553366 [TBL] [Abstract][Full Text] [Related]
38. [Combined antimalarial therapy using artemisinin]. Majori G Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693 [TBL] [Abstract][Full Text] [Related]
39. The role of upstream open reading frames in translation regulation in the apicomplexan parasites Kaur C; Patankar S Parasitology; 2021 Sep; 148(11):1277-1287. PubMed ID: 34099078 [TBL] [Abstract][Full Text] [Related]